On June 4, 2026, Oura began shipping the Oura Ring 5 — announced May 28, 2026 — positioning it as both the world's smallest smart ring and its most clinically ambitious. The device is 40% smaller than its predecessor, built from lightweight, non-allergenic titanium, priced starting at $399 for base finishes, and backed by a hardware architecture the company says delivers greater sensing accuracy across more finger types and skin tones than any previous generation.
But the hardware story is almost secondary to what the software is doing. Oura Ring 5 launches with a suite of health features that move the device from the wellness tracking category into a space that clinicians, researchers, and technology analysts are paying close attention to: continuous, passive biosensing as a tool for preventive and predictive health monitoring.
Oura CEO Tom Hale told CNBC's Andrew Ross Sorkin: "We have finally achieved what I think seems like a real technological miracle. This is what our members have been asking us for, for years." The company, which filed a draft S-1 IPO prospectus with the Securities and Exchange Commission in May 2026, projects nearly $2 billion in 2026 sales, has reported an 80% subscription renewal rate, and expects to surpass five million paid members this quarter.
What's New — and What It Could Mean for Preventive Health
The most clinically significant new features in the Oura Ring 5 platform are not incremental upgrades to step counting or sleep tracking. They represent a substantive move toward real-time biosignal monitoring integrated with clinical health data.
Health Radar and Blood Pressure Signals. Oura's new Health Radar system expands on its earlier Symptom Radar (which used biometric shifts to flag early illness) to now include Blood Pressure Signals — continuous monitoring of nighttime blood pressure patterns. Oura emphasizes nighttime data because sleep provides a cleaner physiological window with fewer confounding variables like caffeine, stress, and physical activity. The company states that changes in nighttime blood pressure patterns may indicate cardiovascular strain and prompt users to seek clinical evaluation. This is not a blood pressure cuff — it is a pattern-detection system using photoplethysmography and other sensors. Clinicians have noted that such signals, while not diagnostically equivalent to clinical measurements, can be meaningful early prompts for medical evaluation, particularly for detecting hypertension patterns that might otherwise go unrecognized.
Lab Uploads. Starting June 30, 2026, members can import laboratory blood work results directly into the Oura app, placing clinical biomarkers — cholesterol, blood glucose, thyroid panels, and other results — alongside continuous wearable data. The integration creates the first commercially available platform through which a consumer can view, in one interface, their real-world clinical lab results and their continuous biometric signals from a wearable device.
GLP-1 Insights. For users taking GLP-1 receptor agonist medications — the fastest-growing drug class in the United States, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — Oura's new GLP-1 Insights feature allows dose logging, side-effect tracking, weight and body change monitoring, and integration with sleep, activity, readiness, and stress data. This gives patients and their physicians a longitudinal view of how GLP-1 therapy is affecting real-world sleep, recovery, and activity patterns — data that is not captured by clinical visits alone.
Brain Health Study. Through an IRB-approved study in Oura Labs, members in the United States who opt in are invited to participate in a research collaboration pairing scientifically validated digital cognitive assessments from Cambridge Cognition with Oura's continuous sleep, activity, and physiological data. The study aims to explore associations between daily behavioral patterns and cognitive function over time — a longitudinal dataset that would be extraordinarily difficult to build through traditional clinical research infrastructure.
| Feature | Availability | What It Tracks |
| Health Radar / Blood Pressure Signals | US, India, UAE — June 2026 | Nighttime blood pressure patterns |
| Nighttime Breathing | US, India, UAE — June 2026 | Breathing disturbances during sleep |
| GLP-1 Insights | US, India, UAE — June 4, 2026 | Dose, side effects, weight, biometric response |
| Lab Uploads | Global — June 30, 2026 | Blood work results alongside biometric data |
| AI-enabled clinical care (Counsel Health) | US 43 states — June 2026 | Personalized health guidance via AI |
| Brain Health Study (IRB-approved) | US opt-in — May 28, 2026 | Cognition vs. sleep/activity patterns |
| Device size vs. prior generation | 40% smaller | — |
| Starting price | $399 (base) / $499 (premium) | — |
The Broader Wearable Health Landscape — and the Questions That Remain
The Oura Ring 5 arrives at a moment when the health wearables sector is undergoing a fundamental shift in ambition. As reported by MD+DI, several medtech companies, including continuous glucose monitor producers, other wearables companies, and even smart contact lens providers, have been working toward the vision of a device that delivers clinically meaningful early-warning data. Oura Ring 5 is the first mass-market consumer wearable to bring that vision as close to clinical integration as it has yet reached.
The company's partnership with Counsel Health for AI-enabled care — available in 43 states — allows Oura members to receive AI-driven health guidance that incorporates their continuous biometric data. This is not a diagnostic service; it is designed as a supportive layer that connects what the ring is measuring to actionable health guidance. But it represents a structurally new kind of healthcare interaction: continuous, passive biosensing informing AI-guided personalized health recommendations in near real time.
Important limitations remain. Blood pressure signals from a photoplethysmography-based ring are not clinically validated diagnostic measurements; they are pattern indicators. Lab uploads enable context-setting, not clinical diagnosis. The brain health study is research, not a clinical tool. Clinicians caution that wearable health data, while genuinely valuable for trend identification and early prompting, should complement — not replace — periodic clinical evaluation, laboratory testing, and physician judgment.
Oura's chief product officer Holly Shelton stated at launch: "To make something 40 percent smaller without sacrificing an ounce of accuracy, we had to rethink every assumption — the sensors, the battery, the architecture, the geometry of the ring itself. The result is the most capable wearable we've ever made — small enough to fit seamlessly into everyday life, and significant enough to set a new standard."
For consumers interested in continuous health monitoring, the Oura Ring 5 is available at Amazon, Best Buy, Costco, Target, and Walmart, with a mandatory membership subscription of $5.99 per month required for full feature access.
Frequently Asked Questions
What is the Oura Ring 5, and when did it launch?
The Oura Ring 5 is the fifth generation of Oura's smart ring health tracker. It was announced May 28, 2026 and began shipping June 4, 2026. It is 40% smaller than its predecessor, priced starting at $399, and requires a $5.99/month membership for full feature access.
Can the Oura Ring 5 measure blood pressure?
Not in the traditional sense. The new Health Radar feature tracks nighttime blood pressure patterns and signals using photoplethysmography sensors. This is designed to detect trends and prompt clinical evaluation — it is not a diagnostic blood pressure measurement equivalent to a clinical cuff reading.
What is the Lab Uploads feature?
Starting June 30, 2026, members can import their blood work and laboratory results into the Oura app, placing clinical biomarkers alongside continuous biometric data from the ring in one view. This allows users to see how sleep, activity, and physiological signals correlate with lab results over time.
Is the Oura Brain Health Study a medical clinical trial?
The Brain Health Study is an IRB-approved research study available to eligible Oura members in the United States who opt in. It pairs validated cognitive assessments from Cambridge Cognition with Oura's continuous biometric data to explore links between daily behaviors and cognitive function. It is a research study, not a clinical diagnostic tool.
Where can I buy the Oura Ring 5?
The Oura Ring 5 is available at ouraring.com and at U.S. retailers including Amazon, Best Buy, Costco, Target, and Walmart. Base finishes (Silver and Black) start at $399; premium finishes (Gold, Stealth, Brushed Silver, Deep Rose) are $499.
